Challenges of Retinoblastoma management at a Nigerian tertiary eyecare facility

Simple item page
dc.contributor.authorMusa, K.O.
dc.contributor.authorAribaba, O.T.
dc.contributor.authorOluleye, T.S.
dc.contributor.authorOlowoyeye, A.O.
dc.contributor.authorAkinsete, A.M.
dc.date.accessioned2019-12-10T13:21:26Z
dc.date.available2019-12-10T13:21:26Z
dc.date.issued2017-10
dc.descriptionStaff publicationsen_US
dc.description.abstractBackground: Retinoblastoma is the most common intraocular childhood malignancy. Its management is, however, not without challenges especially in a developing country like Nigeria. This study sought to present the clinical profile and treatment outcome of patients with retinoblastoma managed in a Nigerian tertiary eye care facility highlighting the challenges with a view to improving the management of the disease. Materials and Methods: A retrospective, single-institution, and institutional review board-approved review of all patients diagnosed with retinoblastoma between January 2012 and December 2015 was done. Data obtained from case files of patients include demographic characteristics, presenting complaint, laterality of disease, tumor stage using the International Intraocular Retinoblastoma Classification, treatment, and outcome. Information obtained from phone calls to the caregivers were also summarized. Results: The review included 54 eyes of 41 patients between the ages of 2 months and 5 years. The mean age at presentation was 24.4 ± 11.4 months. There were 18 males (43.9%). Duration of symptoms before presentation ranged from 2 weeks to 2 years. Tumor was bilateral in 13 (31.7%) patients. Leukocoria was the most common presenting complaint observed in 32 (59.2%) eyes. Groups D and E were the most common intraocular tumor stage documented in 16 (29.7%) and 15 (27.8%) eyes, respectively. Most patients (29, 70.7%) defaulted from treatment after the first or second presentation. Only 6 (21.4%) of 28 patients offered enucleation or modified exenteration either at presentation (Class E) or after chemoreduction (orbital disease) consented. Conclusion: Late presentation, high default rate, and noncompletion of treatment were the major challenges facing retinoblastoma management in this centeren_US
dc.identifier.citationMusa KO, Aribaba OT, Oluleye TS, Olowoyeye AO, Akinsete AM. Challenges of Retinoblastoma management at a Nigerian tertiary eyecare facility in. Journal of Clinical Sciences. 2017 October; 14(4):182-7en_US
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/7064
dc.language.isoenen_US
dc.publisherMedKnowen_US
dc.relation.ispartofseriesJournal of Clinical Sciences;Vol.14(4)
dc.subjectRetinoblastomaen_US
dc.subjectintraocular childhood malignancyen_US
dc.subjectPatientsen_US
dc.subjectEye care facilityen_US
dc.subjectResearch Subject Categories::MEDICINEen_US
dc.titleChallenges of Retinoblastoma management at a Nigerian tertiary eyecare facilityen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Retinoblastoma paper.pdf
Size:
704.92 KB
Format:
Adobe Portable Document Format
Description:
Main article
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Paediatrics- Scholarly Publications